Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Study Title
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Teva Identifier
- TVP - 1012/135 Open Label
- ClinicalTrials.gov Identifier
- NCT00203164
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age Range
- 30 Years and older
- Trial Duration
- 05/01/2002 - 09/01/2006
- Phase
- Phase 3
